Barclays’s Vivani Medical VANI Stock Holding History

Barclays’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$822	Buy	+663	New	+$802	﹤0.01%	4948
2025 Q4	–	Sell	-9	Closed	-$13	–	5715
2025 Q3	$13	Buy	+9	New	+$12	﹤0.01%	5384
2017 Q2	–	Sell	-89	Closed	-$2K	–	6961
2017 Q1	$2K	Sell	89 -32	-26%	-$1.23K	﹤0.01%	6501
2016 Q4	$6K	Buy	121 +117	+2,925%	+$6.68K	﹤0.01%	6097
2016 Q3	$0	Sell	4 -44	-92%	-$3.89K	﹤0.01%	6809
2016 Q2	$4K	Buy	48 +47	+4,700%	+$4.89K	﹤0.01%	5806
2016 Q1	$0	Buy	+1	New	+$115	﹤0.01%	6456
2015 Q4	–	Sell	-3	Closed	–	–	6609
2015 Q3	$0	Sell	3 -6	-67%	-$1.67K	﹤0.01%	7067
2015 Q2	$3K	Buy	9 +4	+80%	+$1.28K	﹤0.01%	6704
2015 Q1	$1K	Sell	5 -5	-50%	-$1.39K	﹤0.01%	6992
2014 Q4	$2K	Buy	+10	New	+$3.49K	﹤0.01%	7124

Other funds holding VANI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays's VANI Position: Q2 2026 in Review

Barclays opened a new position in Vivani Medical (VANI) in Q2 2026: 663 shares worth $822. The stake represents ﹤0.01% of the portfolio and ranks #4948 among its holdings. This is a return to the name: Barclays previously reported a position in VANI as recently as Q3 2025.

Barclays first reported a position in VANI in Q4 2014 and has held it in 11 quarters since. The position peaked at $6K in Q4 2016. 38 funds tracked by Wall St. Rank hold VANI as of Q2 2026.

Barclays held 663 shares of Vivani Medical worth $822 as of Q2 2026.
Vivani Medical was a new Barclays position in Q2 2026.
Vivani Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4948 holding.
Barclays first reported a position in Vivani Medical in Q4 2014 and has held it in 11 quarters since.
Barclays's Vivani Medical position peaked at $6K in Q4 2016.
38 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.